COVID-19 in Pediatric Cancer Patients and Hematopoietic Stem Cell Transplant Recipients in a Tertiary Care Hospital in Argentina.
Journal
Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928
Informations de publication
Date de publication:
01 08 2023
01 08 2023
Historique:
received:
17
10
2022
accepted:
23
04
2023
medline:
28
7
2023
pubmed:
14
6
2023
entrez:
14
6
2023
Statut:
ppublish
Résumé
The outcome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in cancer pediatric patients was initially uncertain. The objective of this study was to describe the characteristics and outcome of cancer patients and hematopoietic stem cell transplant recipients from 0 to 19 years with detectable SARS-CoV-2 from April 23, 2020, to April 30, 2022, treated in a tertiary-level hospital in Argentina. A total of 348 cases were registered in 339 patients. The median age was 89.5 (3 to 224) months. The sex was predominantly male: 193 (55.5%). The most common malignant disease was leukemia (42.8%). One hundred four cases (29.9%) had comorbidities. Of the 346 cases with an available blood count, 17.6% had a lymphocyte count <300/mm 3 . Fever was the most common symptom. In most cases (93.1%) presented asymptomatic or mild disease. Twenty-one cases (6%) presented severe or critical status. Eleven of 24 admissions to the intensive care unit were due to COVID-19 (coronavirus disease 2019). Eight patients (2.3%) died. Two deaths were attributable to SARS-CoV-2 (0.6%). Being older, having fever, lymphopenia at diagnosis, and having received hematopoietic stem cell transplant were associated with a more severe disease. Around 90% of the children continued their cancer treatment without any change.
Identifiants
pubmed: 37314943
doi: 10.1097/MPH.0000000000002691
pii: 00043426-202308000-00015
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e671-e677Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Pan American Health Organization. Coronavirus. Accessed March 11, 2020. https://www.paho.org/es/temas/coronavirus
Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–337.
Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10:783–791.
Montoya J, Ugaz C, Alarcon, et al. COVID-19 in pediatric cancer patients in a resource-limited setting: national data from Peru. Pediatr Blood Cancer. 2021;68:e28610.
López-Aguilar E, Cárdenas-Navarrete R, Simental-Toba A, et al. Children with cancer during COVID-19 pandemic: early experience in Mexico. Pediatr Blood Cancer. 2021;68:e28660.
Graetz D, Agulnik A, Ranadive R, et al. Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study. Lancet Child Adolesc Health. 2021;5:332–340.
Bisogno G, Provenzi M, Zama D, et al. Clinical characteristics and outcome of severe acute respiratory syndrome coronavirus 2 infection in Italian Pediatric Oncology Patients: a study from the Infectious Diseases Working Group of the Associazione Italiana di Oncologia e Ematologia Pediatrica. J Pediatric Infect Dis Soc. 2020;9:530–534.
Madhusoodhan P, Pierro J, Musante J, et al. Characterization of COVID-19 disease in pediatric oncology patients: the New York-New Jersey regional experience. Pediatr Blood Cancer. 2021;68:e28843.
Vijenthira A, Gong IY, Fox TA, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136:2881–2892.
Ferrari A, Zecca M, Rizzari C, et al. Children with cancer in the time of COVID-19: an 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy. Pediatr Blood Cancer. 2020;67:e28410.
de Rojas T, Pérez-Martínez A, Cela E, et al. COVID-19 infection in children and adolescents with cancer in Madrid. Pediatr Blood Cancer. 2020;67:e28397.
Burd E. Validation of laboratory-developed molecular assays for infectious diseases. Clin Microbiol Rev. 2010;23:550–576.
Bustin S, Benes V, Garson J, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55:611–622.
Steliarova-Foucher E, Stiller C, Lacour B, et al. International Classification of Childhood. Cancer. 2005;103:1457–1467.
Centers for Disease Control and Prevention (CDC). 2000 CDC Growth Charts—United States. 2009. https://www.cdc.gov/growthcharts/cdc_charts.htm
World Health Organization (WHO). Body mass index-for-age (BMI-for-age). 2009. https://www.who.int/toolkits/child-growth-standards/standards/body-mass-index-for-age-bmi-for-age
Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145:e20200702.
Ministry of Health of Argentina (Ministerio de Salud de Argentina). Sala de Situación COVID-2019 Nuevo coronavirus 2019 Personas en edad escolar Niñez/Adolescencia y COVID-19 Información disponible al 21/03/2022, SE 11 completa.
Gentile A, Juárez M, Romero Bollón L, et al. A multicenter study of confirmed COVID-19 cases: preliminary data on 2690 pediatric patients in Argentina during the first year of the pandemic. Arch Argent Pediatr. 2022;120:80–88.
Kamdar KY, Kim TO, Doherty EE, et al. COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas. Pediatr Hematol Oncol. 2021;38:695–706.
Mukkada S, Bhakta N, Chantada G, et al. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study. Lancet Oncol. 2021;22:1416–1426.
Boulad F, Kamboj M, Bouvier N, et al. COVID-19 in children with cancer in New York City. JAMA Oncol. 2020;6:1459–1460.
Zachariah P, Johnson C, Halabi K, et al. Epidemiology, clinical features, and disease severity in patients with coronavirus disease 2019 (COVID-19) in a Children’s Hospital in New York City, New York. JAMA Pediatr. 2020;174:e202430.
Cabarcos M, Onoratelli M, Lorenzo M, et al. Cribado de SARS-CoV-2 en pacientes pediátricos con cáncer previo a hospitalización para infusión de quimioterapia. Arch Argent Pediatr. 2022;120:118–121.
Salazar MR, González SE, Regairaz L, et al. Risk factors for COVID-19 mortality: the effect of convalescent plasma administration. PLoS One. 2021;16:e0250386.
Xu X, Han M, Li T, et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci USA. 2020;117:10970–10975.
Ljungman P, de la Camara R, Mikulska M, et al. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey. Leukemia. 2021;35:2885–2894.
González Vicent M, Pérez Martinez A, Trabazo Del Castillo M, et al. COVID-19 in pediatric hematopoietic stem cell transplantation: the experience of Spanish Group of Transplant (GETMON/GETH). Pediatr Blood Cancer. 2020;67:e28514.
Dolan S, Mulcahy Levy J, Moss A, et al. SARS-CoV-2 persistence in immunocompromised children. Pediatr Blood Cancer. 2021;68:e29277.